Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures.

Hassan AE, Memon MZ, Georgiadis AL, Vazquez G, Suri MF, Qureshi AI.

Neurocrit Care. 2011 Aug;15(1):96-100. doi: 10.1007/s12028-010-9421-7.

PMID:
20721698
2.

Bivalirudin: a direct thrombin inhibitor.

Gladwell TD.

Clin Ther. 2002 Jan;24(1):38-58. Review.

PMID:
11833835
3.

Bivalirudin administration during percutaneous coronary intervention: emphasis on high-risk patients.

Seybert AL.

Pharmacotherapy. 2002 Jun;22(6 Pt 2):112S-118S. Review.

PMID:
12064568
4.

Clinical applications of bivalirudin in the cardiac catheterization laboratory.

Thompson KA, Philip KJ, Schwarz ER.

J Cardiovasc Pharmacol Ther. 2011 Jun;16(2):140-9. doi: 10.1177/1074248410385682. Epub 2010 Nov 19. Review.

PMID:
21097669
5.
6.

Use of prolonged bivalirudin infusions following percutaneous coronary intervention.

Moser LR, Nemerovski CW, Good KL.

Cardiovasc Drugs Ther. 2011 Jun;25(3):267-76. doi: 10.1007/s10557-011-6293-9. Review.

PMID:
21479645
7.

Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials.

De Luca G, Cassetti E, Verdoia M, Marino P.

Thromb Haemost. 2009 Sep;102(3):428-36. doi: 10.1160/TH09-05-0287. Review.

PMID:
19718462
9.

Bivalirudin.

Warkentin TE, Greinacher A, Koster A.

Thromb Haemost. 2008 May;99(5):830-9. doi: 10.1160/TH07-10-0644. Review.

PMID:
18449412
10.

Bivalirudin: in patients with acute coronary syndromes : planned for urgent or early intervention.

Deeks ED, Curran MP.

Drugs. 2008;68(16):2345-56. doi: 10.2165/0003495-200868160-00006. Review.

PMID:
18973397
11.

Evolving role of bivalirudin in percutaneous coronary interventions; impact of the REPLACE-2 study.

Salam AM.

Expert Opin Investig Drugs. 2003 Jun;12(6):1027-33. Review.

PMID:
12783606
12.

Bivalirudin as an Alternative to Heparin for Anticoagulation in Infants and Children.

Buck ML.

J Pediatr Pharmacol Ther. 2015 Nov-Dec;20(6):408-17. doi: 10.5863/1551-6776-20.6.408. Review.

13.

Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.

McNair E, Marcoux JA, Bally C, Gamble J, Thomson D.

Perfusion. 2016 Apr;31(3):189-99. doi: 10.1177/0267659115583525. Epub 2015 May 1. Review.

PMID:
25934498
14.

Interventional neurovascular disease: avoidance and management of complications and review of the current literature.

Lawson MF, Velat GJ, Fargen KM, Mocco J, Hoh BL.

J Neurosurg Sci. 2011 Sep;55(3):233-42. Review.

PMID:
21968586
15.

Off-label use of drugs and devices in the neuroendovascular suite.

Abdihalim MM, Hassan AE, Qureshi AI.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2054-63. doi: 10.3174/ajnr.A3447. Epub 2013 Mar 21. Review.

Items per page

Supplemental Content

Write to the Help Desk